Sequent Scientific Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 3,666.68 million compared to INR 3,837.09 million a year ago. Revenue was INR 3,684.05 million compared to INR 3,874.79 million a year ago. Net loss was INR 935.75 million compared to net income of INR 88.26 million a year ago. Basic loss per share from continuing operations was INR 3.77 compared to basic earnings per share from continuing operations of INR 0.35 a year ago. Diluted loss per share from continuing operations was INR 3.77 compared to diluted earnings per share from continuing operations of INR 0.34 a year ago.
For the full year, sales was INR 14,209.09 million compared to INR 14,128.16 million a year ago. Revenue was INR 14,272.99 million compared to INR 14,236.61 million a year ago. Net loss was INR 1,211.6 million compared to net income of INR 409.55 million a year ago. Basic loss per share from continuing operations was INR 4.88 compared to basic earnings per share from continuing operations of INR 1.65 a year ago. Diluted loss per share from continuing operations was INR 4.88 compared to diluted earnings per share from continuing operations of INR 1.63 a year ago.